Susan Weinbach
About Susan Weinbach
Susan Weinbach is the Director of Regulatory Affairs at Bristol Myers Squibb with over twenty years of experience in the biopharmaceutical industry, focusing on regulatory affairs.
Current Position at Bristol Myers Squibb
Susan Weinbach currently holds the position of Director of Regulatory Affairs at Bristol Myers Squibb. In this role, she is responsible for overseeing regulatory strategies and submissions, ensuring compliance with global regulatory requirements. Her extensive experience in regulatory affairs contributes significantly to the company's success in navigating complex regulatory landscapes.
Professional Experience at Celgene
Susan Weinbach served as Director of Regulatory Affairs at Celgene from 2018 to 2019. Based in the Greater San Diego Area, she was instrumental in managing regulatory affairs, including the preparation and submission of regulatory documents. Her role involved collaborating with interdisciplinary teams and ensuring regulatory compliance for Celgene's biopharmaceutical products.
Key Roles at Conventus Biomedical Solutions, Inc.
From 2017 to 2018, Susan Weinbach was the Director of Regulatory Affairs at Conventus Biomedical Solutions, Inc., following her tenure as Associate Director from 2013 to 2016. During her time with Conventus, Susan managed regulatory strategies and submissions, focusing on biologics, drugs, and medical devices. Her role included handling global submissions and regulatory approvals, significantly contributing to the company's operations in the Greater San Diego Area.
Educational Background
Susan Weinbach has an impressive academic background in Chemistry. She earned her Ph.D. in Chemistry (Materials and Interfaces) from the Weizmann Institute of Science, MA in Chemistry from Princeton University, and BA in Chemistry from Oberlin College. Additionally, she completed NIH Postdoctoral Fellowships at UC Santa Barbara and the University of Rochester School of Medicine and Dentistry, which further enriched her expertise in the field.
Biopharmaceutical Industry Experience
With over twenty years of experience in the biopharmaceutical industry, Susan Weinbach has a robust background in regulatory affairs. She has worked with various companies, including Shire Regenerative Medicine, Ceregene, Inc., Biogen, Datafarm Inc, and Isis Pharmaceuticals. Her roles have involved preparing regulatory submissions such as INDs, NDAs, BLAs, and CTAs, as well as managing global submissions and regulatory approvals for FDA, EMA, and Health Canada.